A few successful chemopreventive agents that have been used in OTR patients who are at high risk for the development of skin cancer include retinoids, cyclooxygenase inhibitors, and ornithine decarboxylase (ODC) inhibitors such as DFMO[18]. This evidence concerns the gene ODC1 and skin neoplasm.